(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Loss of FGF8 signaling in the SHF and pharyngeal endoderm disrupts BMP
and TGFβ signaling. (A,B) Intensity maps of
relative expression of members and targets of the FGF and BMP/TGFβ
signaling pathways obtained from four Agilent microarrays comparing
Fgf8;Isl1Cre mutant to control OFTs. Red indicates increased
expression and green decreased expression in mutants. Note the reproducible
direction and magnitude of the changes. In the BMP/TGFβgene list, BMP
pathway members are in bold, TGFβ pathway members are in regular type and
shared genes are marked with an asterisk. Fold changes are log base 2;
P<0.05. (C-E) mRNA in situ hybridizations of E9.5 control
and Fgf8;Isl1Cre mutants. Bmp4 expression is decreased in
the OFT (arrowhead) and SHF (arrow) of (D) Fgf8;Isl1Cre and (E)
Fgfr1c/c;Fgfr2c/+;Isl1Cre mutants that develop
PTA. (F,G) Anti-phosphoSMAD1/5/8 immunohistochemistry on
sagittal sections of control versus Fgf8;Isl1Cre mutant OFTs. Hoechst
staining in blue, anti-pSMAD in red. pSMAD+ cells are abundant in
control, compared with mutant, pharyngeal and subendothelial mesenchyme
(arrows) and in the OFT endothelium (arrowheads). cu, proximal OFT cushion;
PA, pharyngeal arch. (H-I') Anti-phosphoSMAD1/5/8
immunohistochemistry on transverse sections of control versus
Spry2-GOF;Mesp1Cre mutant OFTs. Hoechst staining in blue, anti-pSMAD
in red. pSMAD+ cells are abundant in control OFT endothelium
(arrowheads) and in subendothelial mesenchymal cells (arrows). (H,I) Distal
OFT cushions (cu). (H',I') Proximal OFT cushions. Bracket in
H' shows large numbers of pSMAD+ endothelial cells in the
control.